RISVUTATUG REZETECAN
UNII 7T9A6CKG67

Substance Identification & Data

This profile provides standardized clinical and technical data for Risvutatug Rezetecan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 7T9A6CKG67.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3042849-33-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
7T9A6CKG67
CAS Registry Number
3042849-33-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
RISVUTATUG REZETECAN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C187121
National Cancer Institute reference terminology for clinical and research data.
INN ID
13784
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Risvutatug Rezetecan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

RISVUTATUG REZETECAN

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN B7 HOMOLOG PROTEIN B7H3) (HUMAN MONOCLONAL GSK5764224 .GAMMA.-CHAIN), DISULFIDE WITH (DE-C-TERMINAL-SERINE) HUMAN MONOCLONAL GSK5764224 .LAMBDA.-CHAIN, DIMER, REDUCED, 215'',222,228,231'-TETRAKIS(THIOETHER) WITH N-(6-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)-1-OXOHEXYL)GLYCYLGLYCYL-L-PHENYLALANYL-N-(((1R)-1-CYCLOPROPYL-2-(((1S,9S)-9-ETHYL-5-FLUORO-2,3,9,10,13,15-HEXAHYDRO-9-HYDROXY-4-METHYL-10,13-DIOXO-1H,12H-BENZO(DE)PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLIN-1-YL)AMINO)-2-OXOETHOXY)METHYL)GLYCINAMIDE
IMMUNOGLOBULIN G1-LAMBDA1, ANTI-(HOMO SAPIENS CD276 (B7H3, B7-H3, B7-RELATED PROTEIN 2, B7RP2, B7RP-2, B7 HOMOLOG 3, B7 HOMOLOGUE 3)), HOMO SAPIENS MONOCLONAL ANTIBODY; CONJUGATED ON AN AVERAGE OF FOUR CYSTEINYL RESIDUES TO REZETECAN, COMPRISING A LINKER AND A CAMPTOTHECIN DERIVATIVE (EXATECAN) (RISVUTATUG REZETECAN)
RISVUTATUG REZETECAN [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus